FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2162008912> ?p ?o ?g. }

• W2162008912 endingPage "226" @default.
• W2162008912 startingPage "219" @default.
• W2162008912 abstract "To determine the endometrial response and bleeding patterns in post-menopausal women who were given a sequential hormone replacement regimen with estradiol 2 mg and dydrogesterone 10 mg.One-hundred-and-eighty-eight (188) post-menopausal women with amenorrhea of 6 months or longer, with FSH/estradiol (E2) levels in the post-menopausal range and normal endometrium were entered in the study. All patients received a daily dose of 2 mg E2 during day 1-14 of each 28 day cycle and 2 mg E2 combined with 10 mg dydrogesterone during cycle day 15-28. The total duration of treatment was 12 months (13 cycles of 28 days).The rate of adequate progestational response (secretory or atrophic) in the 146 patients who remained in the study for at least 356 days with 90% study medication compliance and received an endometrial biopsy after 13 cycles of study medication was 97.2%. Three patients had proliferative endometrium and one simple hyperplasia. Cyclic bleedings in the 153 women who remained on study medication for at least 76 days occurred in over 85% of all cycles; the day of onset occurring regularly on day 13 or 14 of the combined period; the mean duration of bleeding per cycle was approximately 5 days with most patients having (very) slight bleeding. Sixty percent of patients had no intermittent bleedings over the whole 12-month study period. The average incidence of intermittent bleeding in the remaining patients was only 2.7 and generally of very slight quantities and of short duration. Per evaluable cycle the percentage of patients with an intermittent bleeding varies from 4.6 to 9.8%. Only two patients discontinued therapy because of bleeding problems. A clear decrease in the incidence of typical menopausal symptoms, i.e. hot flushes and night sweats was observed by the first visit after 6 weeks of treatment.The endometrial safety of 2 mg E2 sequentially combined with 10 mg dydrogesterone is very good as determined by the histologic response of the endometrium. The incidence of cyclic bleedings with this combination therapy is very high as is the regularity of day of onset and duration of bleeding. Blood loss during intermittent bleedings was mild and of short duration." @default.
• W2162008912 created "2016-06-24" @default.
• W2162008912 creator A5048658226 @default.
• W2162008912 creator A5065565827 @default.
• W2162008912 date "1997-04-01" @default.
• W2162008912 modified "2023-10-18" @default.
• W2162008912 title "Endometrial histology and bleeding patterns in post-menopausal women taking sequential, combined estradiol and dydrogesterone" @default.
• W2162008912 cites W125936910 @default.
• W2162008912 cites W2024536285 @default.
• W2162008912 cites W2050108803 @default.
• W2162008912 cites W2063031738 @default.
• W2162008912 cites W2073585987 @default.
• W2162008912 cites W2079450135 @default.
• W2162008912 cites W2082187152 @default.
• W2162008912 cites W2086356273 @default.
• W2162008912 cites W2089707078 @default.
• W2162008912 cites W2107953284 @default.
• W2162008912 cites W2125469710 @default.
• W2162008912 cites W2155439584 @default.
• W2162008912 cites W2172094497 @default.
• W2162008912 cites W2404582322 @default.
• W2162008912 cites W2416224392 @default.
• W2162008912 cites W2466028465 @default.
• W2162008912 doi "https://doi.org/10.1016/s0378-5122(97)01104-3" @default.
• W2162008912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9147354" @default.
• W2162008912 hasPublicationYear "1997" @default.
• W2162008912 type Work @default.
• W2162008912 sameAs 2162008912 @default.
• W2162008912 citedByCount "36" @default.
• W2162008912 countsByYear W21620089122013 @default.
• W2162008912 countsByYear W21620089122018 @default.
• W2162008912 countsByYear W21620089122021 @default.
• W2162008912 crossrefType "journal-article" @default.
• W2162008912 hasAuthorship W2162008912A5048658226 @default.
• W2162008912 hasAuthorship W2162008912A5065565827 @default.
• W2162008912 hasConcept C120665830 @default.
• W2162008912 hasConcept C121332964 @default.
• W2162008912 hasConcept C126322002 @default.
• W2162008912 hasConcept C2776045411 @default.
• W2162008912 hasConcept C2776606343 @default.
• W2162008912 hasConcept C2777164284 @default.
• W2162008912 hasConcept C2777902738 @default.
• W2162008912 hasConcept C2778058571 @default.
• W2162008912 hasConcept C2778562196 @default.
• W2162008912 hasConcept C2779058012 @default.
• W2162008912 hasConcept C2779076696 @default.
• W2162008912 hasConcept C2779234561 @default.
• W2162008912 hasConcept C2779279991 @default.
• W2162008912 hasConcept C2779742232 @default.
• W2162008912 hasConcept C2780159708 @default.
• W2162008912 hasConcept C2781413609 @default.
• W2162008912 hasConcept C2908647359 @default.
• W2162008912 hasConcept C29456083 @default.
• W2162008912 hasConcept C2986817661 @default.
• W2162008912 hasConcept C54355233 @default.
• W2162008912 hasConcept C61511704 @default.
• W2162008912 hasConcept C71315377 @default.
• W2162008912 hasConcept C71924100 @default.
• W2162008912 hasConcept C86803240 @default.
• W2162008912 hasConcept C99454951 @default.
• W2162008912 hasConceptScore W2162008912C120665830 @default.
• W2162008912 hasConceptScore W2162008912C121332964 @default.
• W2162008912 hasConceptScore W2162008912C126322002 @default.
• W2162008912 hasConceptScore W2162008912C2776045411 @default.
• W2162008912 hasConceptScore W2162008912C2776606343 @default.
• W2162008912 hasConceptScore W2162008912C2777164284 @default.
• W2162008912 hasConceptScore W2162008912C2777902738 @default.
• W2162008912 hasConceptScore W2162008912C2778058571 @default.
• W2162008912 hasConceptScore W2162008912C2778562196 @default.
• W2162008912 hasConceptScore W2162008912C2779058012 @default.
• W2162008912 hasConceptScore W2162008912C2779076696 @default.
• W2162008912 hasConceptScore W2162008912C2779234561 @default.
• W2162008912 hasConceptScore W2162008912C2779279991 @default.
• W2162008912 hasConceptScore W2162008912C2779742232 @default.
• W2162008912 hasConceptScore W2162008912C2780159708 @default.
• W2162008912 hasConceptScore W2162008912C2781413609 @default.
• W2162008912 hasConceptScore W2162008912C2908647359 @default.
• W2162008912 hasConceptScore W2162008912C29456083 @default.
• W2162008912 hasConceptScore W2162008912C2986817661 @default.
• W2162008912 hasConceptScore W2162008912C54355233 @default.
• W2162008912 hasConceptScore W2162008912C61511704 @default.
• W2162008912 hasConceptScore W2162008912C71315377 @default.
• W2162008912 hasConceptScore W2162008912C71924100 @default.
• W2162008912 hasConceptScore W2162008912C86803240 @default.
• W2162008912 hasConceptScore W2162008912C99454951 @default.
• W2162008912 hasIssue "3" @default.
• W2162008912 hasLocation W21620089121 @default.
• W2162008912 hasLocation W21620089122 @default.
• W2162008912 hasOpenAccess W2162008912 @default.
• W2162008912 hasPrimaryLocation W21620089121 @default.
• W2162008912 hasRelatedWork W2003312069 @default.
• W2162008912 hasRelatedWork W2024822867 @default.
• W2162008912 hasRelatedWork W2061508987 @default.
• W2162008912 hasRelatedWork W2065887037 @default.
• W2162008912 hasRelatedWork W2071195414 @default.
• W2162008912 hasRelatedWork W2107953284 @default.
• W2162008912 hasRelatedWork W2126154655 @default.
• W2162008912 hasRelatedWork W2162008912 @default.

• next